COMMUNIQUÉS West-GlobeNewswire

Surface Oncology Announces Upcoming Investor Presentations

20/11/2018 - 13:00

CAMBRIDGE, Mass., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, announced [...]

Eloxx Pharmaceuticals To Present at the 30th Annual Piper Jaffray Healthcare Conference on Wednesday, November 28, 2018

20/11/2018 - 13:00

WALTHAM, Mass., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc., (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic [...]

BioCryst Appoints Rare Disease Expert Theresa Heggie to Board of Directors

20/11/2018 - 13:00

RESEARCH TRIANGLE PARK, N.C., Nov. 20, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company has appointed Theresa Heggie to its Board of Directors. Ms. Heggie currently [...]

Apellis Pharmaceuticals Expands Leadership Team, Appoints Adam Townsend as Chief Commercial Officer

20/11/2018 - 13:00

CRESTWOOD, Ky. and WALTHAM, Mass., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]

Clinical Data from Long-Term Safety-Study of Company’s Pharmaceutical CBD in Refractory Pediatric Epilepsy To Be Presented at American Epilepsy Society Meeting

20/11/2018 - 13:00

PHOENIX, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Clinical data from a long-term safety study of pharmaceutical-grade cannabidiol (CBD) oral solution as an investigational treatment for refractory pediatric epilepsy will be [...]

Ovid Therapeutics Announces OV935/TAK-935 Presentations at the American Epilepsy Society 72nd Annual Meeting

20/11/2018 - 13:00

NEW YORK, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today [...]

Stemline Therapeutics Announces that European Medicines Agency (EMA) Grants Accelerated Assessment for planned ELZONRIS Marketing Authorization Application (MAA)

20/11/2018 - 13:00

NEW YORK, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a biopharmaceutical company focused on the development and potential commercialization of novel oncology therapeutics, announced [...]

ProQR to Present at the Evercore ISI HealthConX Conference

20/11/2018 - 13:00

LEIDEN, the Netherlands, Nov. 20, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe [...]

VBL Therapeutics Announces Third Quarter 2018 Financial Results

20/11/2018 - 13:00

Conference Call and Webcast at 8:30am Eastern Time Today TEL AVIV, Israel, Nov. 20, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) today announced financial results for the third quarter ended September 30, [...]

Medigus Will Form a Separate Company for Its Novel Miniature Video Cameras, Focused on Marketing for New Industries

20/11/2018 - 13:00

The Fully Owned Subsidiary Will Engage in Promoting to New Additional Industries such as Defense, Aviation, Automotive and More OMER, Israel, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (“Medigus” or the “Company”) ( [...]

Cambrex to Acquire Avista Pharma Solutions, Adding Early Stage API and Finished Dosage Form Development & Testing Services to its Global Contract Development & Manufacturing Network

20/11/2018 - 12:40

-- Conference Call at 8:30 a.m. ET Today -- EAST RUTHERFORD, N.J., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading manufacturer of small molecule innovator and generic Active [...]

Emblem Corp. Reports Strong Third Quarter 2018 Financial Results

20/11/2018 - 12:30

Revenues increase 281% over the quarter ended September 30, 2017 and 50% over Q2 2018 TORONTO, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), a licensed producer of [...]

Tetra Bio-Pharma Enters into Binding Proposal with Quantum Pharma Inc.

20/11/2018 - 12:30

Company takes a significant step forward to become a fully integrated drug development company ORLEANS, Ontario, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“ Tetra ” or “ TBP ”), (TSX VENTURE: TBP) (OTCQB [...]

New TRU NIAGEN® Stick Packs Target New Audiences and Consumer Needs

20/11/2018 - 12:30

ChromaDex expands TRU NIAGEN® product line, offering single-serving stick packs for on-the-go consumers and athletes LOS ANGELES, Nov. 20, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today the [...]

Maple Leaf Green World Inc. Enters into a Letter of Intent to Acquire A Production License in Clark County, Nevada

20/11/2018 - 12:30

CALGARY, Alberta, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) ( NEO: MGW, OTCQX: MGWFF ) is pleased to announce that it has expanded its interests in Nevada by [...]

Announcement from major shareholder

20/11/2018 - 12:07

November 20, 2018 Announcement no. 23 Announcement from major shareholder Today, and pursuant to sections 30 and 38 of the Danish Capital Markets Act, BioPorto A/S has received notice that Media-Invest Danmark A/S holds [...]

Arvinas To Present at the 30th Annual Piper Jaffray Healthcare Conference

20/11/2018 - 12:00

NEW HAVEN, Conn., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Arvinas Inc. (Nasdaq: ARVN), a biotechnology company creating a new class of drugs based on protein degradation, today announced that John G. Houston, Ph.D., President [...]

Amarin to Present at the Evercore ISI HealthCONx Conference

20/11/2018 - 12:00

BEDMINSTER, N.J., and DUBLIN, Ireland, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on the commercialization and development of therapeutics to improve [...]

Completion of share capital increase

20/11/2018 - 11:18

November 20, 2018 Announcement no. 22 Completion of share capital increase The Board of Directors of BioPorto A/S (BioPorto) decided on November 11, 2018 to partially exercise the authorization in article 16b of the [...]